苏加马德克斯和神经肌肉疾病:一个系统审查,评估报告质量和内容有效性
Alexis Schneider1, Martin R Tramèr2, Gleicy Keli-Barcelos1
1Division of Anaesthesiology, Department of Anaesthesiology, Pharmacology, Intensive Care and Emergency Medicine, Geneva University Hospitals, Geneva, Switzerland.
British journal of anaesthesia
|July 13, 2024
概括
由于低质量的证据,Sugammadex在神经肌肉疾病中的疗效尚不确定. 进一步的研究需要改进报告标准以进行可靠的安全性和疗效评估.
科学领域:
- 麻醉学和重症监护医学
- 神经学 神经学
- 药理学 药理学是指药理学的学科.
背景情况:
- 在患有神经肌肉疾病的患者中,Sugammadex对逆转神经肌肉阻断剂 (NMBA) 的疗效和安全性尚未得到充分证实.
- 现有的证据主要来自观察性研究,数据质量和有效性受到限制.
研究的目的:
- 系统地审查和评估有关在患有神经肌肉疾病的患者中使用sugammadex的现有证据.
- 评估数据报告的质量和有关NMBAs的sugammadex逆转发表报告的有效性.
主要方法:
- 对任何神经肌肉疾病患者使用sugammadex的观察报告进行了全面的搜索.
- 数据质量使用修改后的CARE检查清单进行评估,有效性使用Delphi开发的特定检查清单进行评估.
主要成果:
- 分析了126份涉及386名患者的观察报告,主要是接受罗库治疗的严重肌痛性肌痛症患者.
- 在接受神经监测的患者中,97.4%的Sugammadex成功逆转了神经肌肉阻塞.
- 在4.2%的患者中报告了不良事件;然而,总体数据质量和有效性得分低至中等.
结论:
- 目前的不受控制的观察表明潜在的疗效,但不允许对Sugammadex在神经肌肉疾病患者的安全性和疗效进行自信评估.
- 改善报告准则对于观察性研究至关重要,强调数据有效性和对现有知识的贡献.
相关概念视频
01:15Myasthenia Gravis: Diagnostic Tests
753
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
753
01:21Skeletal Muscle Relaxants: Adverse Effects
351
Skeletal muscle relaxants are widely used for muscle paralysis and relieving pain following any muscle injury or stiffness. However, depending on the drug type, they can have adverse effects that range from mild to severe. Usually, nondepolarizing neuromuscular blockers have minimal side effects. For example, drugs like d-tubocurarine, cisatracurium, and rocuronium cause hypotension, whereas drugs like baclofen, when stopped abruptly, can lead to the recurrence of spastic conditions.
Unlike...
Unlike...
351
01:31Skeletal Muscle Relaxants: Therapeutic Uses
479
Skeletal muscle relaxants are used to relax muscle tone and alleviate painful muscle contractions. However, the choice of skeletal muscle relaxants depends on the duration of the surgical procedure in order to minimize potential side effects. Skeletal muscle relaxants like neuromuscular blocking agents [NMBAs] are commonly employed as adjuvants alongside general anesthetics in clinical settings. NMBAs are also used to maintain controlled ventilation during surgery of the larynx or pharynx...
479
01:20Myasthenia Gravis: Overview and Treatment
1.3K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.3K